Methods For Engineering T Cells For Immunotherapy By Using Rna-Guided Cas Nuclease System

Patent No. EP3004337 (titled "Methods For Engineering T Cells For Immunotherapy By Using Rna-Guided Cas Nuclease System") was filed by Cellectis on Apr 1, 2014. The application was issued on Aug 2, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BARKER BRETTELLMay 1, 2018BARKER BRETTELL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3004337

CELLECTIS
Application Number
EP14714278A
Filing Date
Apr 1, 2014
Status
Opposition Rejected
Feb 28, 2020
Publication Date
Aug 2, 2017